Concentrations (Tables)

12 Months Ended

Jun. 30, 2013

Concentrations [Abstract]

Product revenues as a percentage of total net revenues

The following is a summary of product revenues as a percentage of total net revenues for the Company’s principal product lines:

	2013			2012			2011
AXP		41	%		39	%		34	%
BioArchive		20	%		21	%		28	%
Other cord blood		13	%		12	%		9	%
Res-Q/MXP		13	%		11	%		10	%
ThermoLine		3	%		4	%		6	%
CryoSeal		2	%		7	%		3	%

Sales to customers

We had sales to customers as follows for the years ended June 30:

	2013		2012		2011
United States	$	8,011,000	$	10,783,000	$	13,745,000
China		2,058,000		609,000		778,000
Hong Kong		2,006,000		514,000		584,000
Asia - other		1,855,000		2,887,000		2,335,000
Europe		2,030,000		1,806,000		3,453,000
South America		831,000		1,505,000		1,904,000
Other		1,172,000		919,000		601,000
	$	17,963,000	$	19,023,000	$	23,400,000

Summary of net equipment by geographic area

The Company has a contract manufacturer in Costa Rica that produces certain disposables. The Company provides AXP equipment to its distributor in China for use by end-user customers. The Company’s net equipment is summarized below by geographic area:

	June 30, 2013		June 30, 2012
United States	$	1,005,000	$	1,269,000
China		678,000		151,000
Costa Rica		403,000		205,000
All other countries		122,000		27,000
Total equipment, net	$	2,208,000	$	1,652,000